DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
7 articles
AI radiotherapy planning is no longer just a lab demonstration: in the ARCHERY trial, it reached a high standard in more than 95% of cervical cancer cases.
In a new analysis, mpox does not behave like an outbreak that can be tracked only through rash, lesions, and patients who know they are sick.
Houston Methodist has used a personalized mRNA vaccine in a patient with osteosarcoma in an attempt to reduce relapse risk under FDA compassionate use.
Current antifungals fail in 40% of systemic candidiasis cases, a mortality rate driving researchers toward radical alternatives like immune metabolic reprogramming.
T cells—immune system’s off-meta pick—just outplayed antibodies in a *Cell Reports* study, targeting viral ‘core files’ instead of mutable cosmetics.
Researchers published findings on April 17 detailing how ML models analyze atopic dermatitis to forecast respiratory illness.
A new amino acid formulation appears to improve LNP uptake in cells, though no human data yet exists.